<?xml version="1.0" encoding="UTF-8"?><!-- generator="WordPress/2.9.2" -->
<rss version="0.92">
<channel>
	<title>ILSI-Biomed Israel</title>
	<link>http://biomed-blogs.com</link>
	<description>Biomedical innovation, healthcare, life sciences and more!</description>
	<lastBuildDate>Tue, 29 Jun 2010 21:52:03 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	
	<item>
		<title>Aiming for Near-Normal Blood Sugar Did Not Delay Combined Risk of Diabetic Damage for People With Long-standing Diabetes, NIH-Sponsored Trial Finds</title>
		<description><![CDATA[
In people with longstanding type 2 diabetes who are at high risk for heart attack and stroke, lowering blood sugar to near-normal levels did not delay the combined risk of diabetic damage to kidneys, eyes, or nerves, but did delay several other signs of diabetic damage, a study has found.  The intensive glucose treatment was compared [...]]]></description>
		<link>http://biomed-blogs.com/biomed2010/665</link>
			</item>
	<item>
		<title>Long-Awaited Bilski Decision Expected Soon</title>
		<description><![CDATA[by GERSON PANITCH, FINNEGAN
 
June 14, 2010
Patent professionals and U.S. Supreme Court watchers alike on high alert as a Bilski decision is expected before the Court’s 2009 term comes to an end this month.  Perhaps no case is more anticipated than the decision in Bilski v. Doll, especially for those in high-tech fields such as telecom, [...]]]></description>
		<link>http://biomed-blogs.com/biomed2010/659</link>
			</item>
	<item>
		<title>BioMed 2010: Merck-Serono reaches out to collaborate with Israeli companies and entrepreneurs</title>
		<description><![CDATA[BioMed 2010: Merck-Serono reaches out to collaborate with Israeli companies and entrepreneurs 

This is done through Inter-lab is the company&#8217;s R&#38;D center in Israel • Inter-Lab CEO, Regine Shevach: &#8220;The Israeli science has a special zest to it, one which we are thrilled to encounter time and time again; Together with Merck Serono, this special [...]]]></description>
		<link>http://biomed-blogs.com/biomed2010/657</link>
			</item>
	<item>
		<title>ILSI-BioMed 2010 Has Begun!</title>
		<description><![CDATA[This morning the ILSI-BioMed Week 2010 has finally been launched, with 7,000 anticipated participants that will take part in lectures and meetings with the experts and seniors of the bio-pharma and medical equipment industry in Israel and abroad.

Following the opening words of the event&#8217;s organizers, ILSI and Kenes, the president of Israel Shimon Peres came [...]]]></description>
		<link>http://biomed-blogs.com/biomed2010/651</link>
			</item>
	<item>
		<title>A French Delegation in the Negev</title>
		<description><![CDATA[A French delegation has visited today (Sunday, 13.6.2010) at Ben-Gurion University, as the guest of Bio-Negev, the international center for innovation in the biotechnology industry and life sciences in the Negev.

The purpose of the visit is to examine potential collaboration between the visitors and the new initiative in the Negev, BGU being one of the [...]]]></description>
		<link>http://biomed-blogs.com/biomed2010/645</link>
			</item>
	<item>
		<title>BioMed 2010 week Innovations: The New Generation of PainShield</title>
		<description><![CDATA[NanoVibronix will present the second generation of PainShield – for the treatment of pain and chronic wounds using ultrasound waves

Following the commercial success of the first generation PainShield device, for the treatment of (surprise, surprise) pain, especially one that stems from Trigeminal Neualgia, the Israeli company NanoVibronix now reveals the second generation of the device. [...]]]></description>
		<link>http://biomed-blogs.com/biomed2010/641</link>
			</item>
	<item>
		<title>Israel&#8217;s Life Sciences Export On the Rise</title>
		<description><![CDATA[The Coming ILSI–Biomed Israel 2010 Week: The Israel Export and International Cooperation Institute: Life Sciences Export Rose by 14% on the First Quarter of 2010, Summing up to the Total of ca. $1.7 Billion

“The first 2010 quarter export of the life sciences industry summed up to ca. $1.7 billion, an increase of about 14 percent [...]]]></description>
		<link>http://biomed-blogs.com/biomed2010/636</link>
			</item>
	<item>
		<title>Stem Cells as Seek-and-Destory Missiles against Cancer</title>
		<description><![CDATA[As published in New Scientist, stem cells were succesfully modified to act as seek-and-destroy missiles against cancer in mice brains

Stem cells are often viewed as the ultimate solution for regenerative medicine, and for a good cause. Given the correct cues, they can regenerate whole parts of the body, and even re-create an entire embryo (although [...]]]></description>
		<link>http://biomed-blogs.com/biomed2010/631</link>
			</item>
	<item>
		<title>Biotech co D Medical files for Nasdaq listing</title>
		<description><![CDATA[Biotech co D Medical files for Nasdaq listing: If the offering is successful, it will greatly dilute the holdings of its current shareholders. 

The management of medical device holding company D Medical Industries Ltd. (TASE:DMDC) are not deterred by the falls on the Tel Aviv Stock Exchange (TASE) and on Wall Street over the past few [...]]]></description>
		<link>http://biomed-blogs.com/ilsi/628</link>
			</item>
	<item>
		<title>A Novel Israeli Kit for Regaining Feeling in the Palms</title>
		<description><![CDATA[Sheba Hospital will expose a Israeli kit for sensory training, that improves the brain activity for patients who suffer from a decrease in feeling in the palms

The Department for Multiple Sclerosis in Sheba Hopsital will present for the first time a novel kit for sensory training, that improves patients&#8217; brain activity. The kit will be [...]]]></description>
		<link>http://biomed-blogs.com/biomed2010/622</link>
			</item>
</channel>
</rss>
